Makingmillions192
Nov 16, 8:38 PM
$LEXX Alto Neuroscience (
$ANRO) — Clinical-Stage Biotech Re-Rating
Armistice built a substantial stake in Alto Neuroscience (holding ~864k shares via 13F/13G disclosures) while the stock was heavily discounted at ~
$4.65—nearly identical to
$LEXX's current ~
$4.44 level.
Bullet The Catalyst & Move: Following clinical pipeline progress and positive Phase 2 psychiatry/biomarker momentum, the stock staged a +535% surge, climbing into the high-
$20S as institutional buyers re-rated its clinical platform.
0 replies